Growing Efforts by Vendors to Offer New Products Pushing Demand within Pleural Catheters Market

Pleural catheters are increasingly used for malignant pleural effusions management. Use of these devices was approved by FDA in 1997. PleurX catheter (BD, USA) and Rocket IPC (Rocket Medical, England) are some of the most common devices in use at present. Key reason behind the profound growth of the global pleural catheters market is improved patient results in reducing clinical variability.

There is rise in demand for these devices from clinical practitioners such as physicians, pulmonologists, and surgeons. The important reason for this demand rise is said to be the ability of pleural catheters to offer effective fluid control. This has helped clinical staff to reduce the risk and improve the quality of patient’s life. This feature of the device is projected to support the growth of the pleural catheters market.

In this article, Fact.MR highlights various trends and key factors that are supporting or hindering the growth of the global pleural catheters market. According to analysts’ finding, this market will show a striking growth at the CAGR of 6.5% during the forecast period of 2019–2029. Growing use of these devices in the management of malignant pleural effusions is supposed to be one of the key reasons for growth of pleural catheters market.

Growing Initiatives to Minimize Patient Hospitalization Pushing Market Demand

Increased efforts from healthcare industry to minimize patient hospitalization are driving the growth of the global pleural catheters market. This has lead to growing inclination toward use of pleural catheters. Demand for pleural catheters is estimated to stimulate with introduction of advanced products by new vendors in the global pleural catheters market. Besides, many private hospitals are opening their centers in rural areas. This move is making the availability of advanced treatment option possible, thereby boosting the demand for pleural catheters in these regions.

Some of the leading vendors in the global pleural catheters market are Rocket Medical, Merit Medical Systems, Becton, Dickinson and Company, Armstrong Medical, and B. Braun Melsungen.

Malignant Pleural Effusions to Gain Maximum Traction in Pleural Catheters Market

Malignant pleural effusion is the most widespread complication of advanced malignancy. Cough, dyspnea, or chest tightness are some of the complications resulting from this health condition. There is increase in usage of pleural catheters in palliative treatment of malignant pleural effusions. The main reason behind this shift is the ability of these devices to offer minimally invasive long-term drainage with minimum chances of pleurodesis. As a result, the use of intrapleural catheters is found to be a better choice, specifically while treating severe health complications. This is triggering the growth of pleural catheters market.

Growing Incorporation of Advanced Technology to Open New Avenues for Market Growth

Many vendors from the pleural catheters market are increasing investments in diverse research and development activities. The main motive of this move is to offer improved products for end-users. This is working as a driving factor for the growth of the global pleural catheters market in the recent times. Moreover, growing prevalence of COPD is one of the key reasons for increased demand for these products.

On regional front, North America is expected to be one of the prominent regions in the global pleural catheters market during the projected period. Some of the reasons behind this projection are rising older population, increased number of chronic respiratory disease cases, and improved accessibility to healthcare facilities.